Lazard Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-642
Closed -$44K 2594
2024
Q3
$44K Hold
642
﹤0.01% 1943
2024
Q2
$43K Sell
642
-57
-8% -$3.84K ﹤0.01% 1956
2024
Q1
$48K Sell
699
-48
-6% -$3.24K ﹤0.01% 1727
2023
Q4
$46K Buy
747
+73
+11% +$4.08K ﹤0.01% 1908
2023
Q3
$37K Hold
674
﹤0.01% 1945
2023
Q2
$34K Hold
674
﹤0.01% 1951
2023
Q1
$36K Sell
674
-5,828
-90% -$340K ﹤0.01% 1901
2022
Q4
$406K Buy
6,502
+674
+12% +$44.7K ﹤0.01% 1159
2022
Q3
$410K Buy
+5,828
New +$402K ﹤0.01% 1134
2022
Q2
Sell
-189
Closed -$11K 2615
2022
Q1
$11K Sell
189
-666
-78% -$35.9K ﹤0.01% 2131
2021
Q4
$47K Buy
855
+135
+19% +$8.25K ﹤0.01% 1772
2021
Q3
$46K Sell
720
-788
-52% -$53.8K ﹤0.01% 1721
2021
Q2
$95K Buy
1,508
+733
+95% +$43.3K ﹤0.01% 1367
2021
Q1
$46K Buy
+775
New +$42.1K ﹤0.01% 1476

Other funds holding AXNX

Lazard Asset Management's AXNX Position: Q4 2024 in Review

Lazard Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 642 shares — an estimated $44K sold.

Lazard Asset Management first reported a position in AXNX in Q1 2021 and held it in 14 quarters. The position peaked at $410K in Q3 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Lazard Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Lazard Asset Management sold 642 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $44K.
  • Lazard Asset Management first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 14 quarters.
  • Lazard Asset Management's Axonics, Inc. Common Stock position peaked at $410K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.